Agios Pharmaceuticals Inc (AGIO) Live Stock Price, Forecast & News

Agios Pharmaceuticals Inc
AGIO
(Nasdaq - US)
Closed
59.07
+3.99 (+7.24%)
in:usd•As of: Nov 08, 2024 15:59 UTC -5
Open
54.50
High
60.18
Low
54.31

Stats
Prev. Close
55.08
Open
54.50
Day's Range
54.31 - 60.18
52 Week Range
20.40 - 60.18
YTD Change
165.24%
1 Year Change
154.17%
Market Cap
3.37B
P/E Ratio
N/A
Volume
37,525
Beta
0.75
Sector
Health Technology
Industry
Pharmaceuticals Major
Economic CalendarAll Events
Time zone: GMT
Thursday, November 7th 2024
Time Currency Event Impact Actual Consensus Previous
19:00

USD
Fed Interest Rate Decision
High
4.75% 4.75% 5%
19:30

USD
Fed Press Conference
High
Friday, November 8th 2024
Time Currency Event Impact Actual Consensus Previous
15:00

USD
Michigan Consumer Sentiment PrelNov
High
73.0 71 70.5
16:00

USD
Fed Bowman Speech
Medium
Tuesday, November 12th 2024
Time Currency Event Impact Actual Consensus Previous
15:00

USD
Fed Waller Speech
Medium
15:15

USD
Fed Barkin Speech
Medium
19:00

USD
Fed Kashkari Speech
Medium
Latest News
Zacks Investment ResearchNov 1, 2024
AGIO's Q3 Earnings Miss Mark, Revenues In Line, Stock Down
AGIO+7.24%
Seeking AlphaOct 31, 2024
Agios Pharmaceuticals, Inc. (AGIO) Q3 2024 Earnings Call Transcript
AGIO+7.24%
Zacks Investment ResearchOct 31, 2024
Agios Pharmaceuticals (AGIO) Misses Q3 Earnings and Revenue Estimates
AGIO+7.24%
Zacks Investment ResearchSep 12, 2024
FDA Grants Orphan Drug Tag to AGIO's Tebapivat for Rare Cancer
AGIO+7.24%
Seeking AlphaAug 27, 2024
Agios' Mitapivat: A Potential Blockbuster In Thalassemia Treatment
AGIO+7.24%
Zacks Investment ResearchAug 2, 2024
AGIO Q2 Earnings Lag, Stock Down on Missing Pediatric Study Goal
AGIO+7.24%
Read All
Data Vendor:
Stocks
Loading
Loading

Thursday, November 7th 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
19:00	USD	Fed Interest Rate Decision	High	4.75%	4.75%	5%
19:30	USD	Fed Press Conference	High

Friday, November 8th 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
15:00	USD	Michigan Consumer Sentiment PrelNov	High	73.0	71	70.5
16:00	USD	Fed Bowman Speech	Medium

Tuesday, November 12th 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
15:00	USD	Fed Waller Speech	Medium
15:15	USD	Fed Barkin Speech	Medium
19:00	USD	Fed Kashkari Speech	Medium

Agios Pharmaceuticals Inc

AGIO's Q3 Earnings Miss Mark, Revenues In Line, Stock Down

Agios Pharmaceuticals, Inc. (AGIO) Q3 2024 Earnings Call Transcript

Agios Pharmaceuticals (AGIO) Misses Q3 Earnings and Revenue Estimates

FDA Grants Orphan Drug Tag to AGIO's Tebapivat for Rare Cancer

Agios' Mitapivat: A Potential Blockbuster In Thalassemia Treatment

AGIO Q2 Earnings Lag, Stock Down on Missing Pediatric Study Goal

Trade With A Regulated Broker